Cargando…
Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393730/ https://www.ncbi.nlm.nih.gov/pubmed/37042968 http://dx.doi.org/10.1182/bloodadvances.2023009818 |
| _version_ | 1785083205975539712 |
|---|---|
| author | Afzal, Amber Fiala, Mark A. Jacoby, Meagan A. Walter, Matthew J. |
| author_facet | Afzal, Amber Fiala, Mark A. Jacoby, Meagan A. Walter, Matthew J. |
| author_sort | Afzal, Amber |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10393730 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103937302023-08-03 Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia Afzal, Amber Fiala, Mark A. Jacoby, Meagan A. Walter, Matthew J. Blood Adv Research Letter The American Society of Hematology 2023-04-14 /pmc/articles/PMC10393730/ /pubmed/37042968 http://dx.doi.org/10.1182/bloodadvances.2023009818 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Research Letter Afzal, Amber Fiala, Mark A. Jacoby, Meagan A. Walter, Matthew J. Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia |
| title | Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia |
| title_full | Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia |
| title_fullStr | Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia |
| title_full_unstemmed | Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia |
| title_short | Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia |
| title_sort | statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393730/ https://www.ncbi.nlm.nih.gov/pubmed/37042968 http://dx.doi.org/10.1182/bloodadvances.2023009818 |
| work_keys_str_mv | AT afzalamber statinuseinmyelodysplasticsyndromesisassociatedwithabettersurvivalanddecreasedprogressiontoleukemia AT fialamarka statinuseinmyelodysplasticsyndromesisassociatedwithabettersurvivalanddecreasedprogressiontoleukemia AT jacobymeagana statinuseinmyelodysplasticsyndromesisassociatedwithabettersurvivalanddecreasedprogressiontoleukemia AT waltermatthewj statinuseinmyelodysplasticsyndromesisassociatedwithabettersurvivalanddecreasedprogressiontoleukemia |